These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4076 related articles for article (PubMed ID: 6556950)

  • 41. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
    Harper JR; Bumol TF; Reisfeld RA
    Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells.
    Savage HE; Rossen RD; Hersh EM; Freedman RS; Bowen JM; Plager C
    Cancer Res; 1986 Apr; 46(4 Pt 2):2127-33. PubMed ID: 3948184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance and nature of circulating immune complexes in melanoma patients.
    Gupta RK; Morton DL
    Contemp Top Immunobiol; 1985; 15():1-53. PubMed ID: 3896641
    [No Abstract]   [Full Text] [Related]  

  • 44. Recovery of immunologically reactive antibodies and antigens from breast cancer immune complexes by preparative isoelectric focusing.
    Maidment BW; Papsidero LD; Nemoto T; Chu TM
    Cancer Res; 1981 Mar; 41(3):795-800. PubMed ID: 7459866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Xenogeneic oncofetal antigen reexpressed in human neoplasia.
    Salinas FA; Wee KH
    Ann N Y Acad Sci; 1980; 349():409-10. PubMed ID: 6939372
    [No Abstract]   [Full Text] [Related]  

  • 46. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
    Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF
    Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
    Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
    Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
    Kirkwood JM; Vlock DR
    Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigenic analysis of immune complexes formed in normal human pregnancy.
    Davies M
    Clin Exp Immunol; 1985 Aug; 61(2):406-15. PubMed ID: 4042429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
    Morgan AC; McIntyre RF
    Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.
    Carey TE; Takahashi T; Resnick LA; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3278-82. PubMed ID: 1067619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG).
    Minden P; Sharpton TR; McClatchy JK
    J Immunol; 1976 May; 116(5):1407-14. PubMed ID: 58033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humoral immune response in melanoma and glioma patients: a solubilized melanoma-membrane component as a tool for detecting circulating antibodies.
    Birkmayer GD
    Cancer; 1981 Dec; 48(11):2399-408. PubMed ID: 7296490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.
    Mattes MJ; Thomson TM; Old LJ; Lloyd KO
    Int J Cancer; 1983 Dec; 32(6):717-21. PubMed ID: 6197381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies.
    Brown JP; Wright PW; Hart CE; Woodbury RG; Hellström KE; Hellström I
    J Biol Chem; 1980 Jun; 255(11):4980-3. PubMed ID: 7372618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteosarcoma patients: isolation of serum antibodies by affinity chromatography.
    Tsang KY; Fudenberg HH; Gnagy MJ
    J Natl Cancer Inst; 1981 Dec; 67(6):1183-9. PubMed ID: 6796743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines.
    Livingston PO; Kaelin K; Pinsky CM; Oettgen HF; Old LJ
    Cancer; 1985 Nov; 56(9):2194-200. PubMed ID: 4052966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
    Bystryn JC; Henn M; Li J; Shroba S
    Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
    Hwang KM; Fodstad O; Oldham RK; Morgan AC
    Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 204.